Kindred Healthcare Announces Fourth Quarter Results and Plans for Ventas Lease Renewals
| Business Wire, Inc. |
Excluding Certain Items, Company Reports Fourth Quarter Continuing Operations Diluted EPS of
Company Reports GAAP Continuing Operations Loss of
Company Reduces Fiscal 2012 Earnings Guidance to
Company Intends to Allow Ventas Leases for 54 Nursing Centers and 10 Hospitals to Expire in 2013
Highlights (operating data adjusted to exclude certain items):
- Favorable impact of
RehabCare acquisition negated by fourth quarter regulatory changes- Initial quarter under new RUGs IV and rehabilitation therapy rule changes more challenging than expected
- Annual impact of new
Medicare rules now estimated at$150 million
- Fourth quarter consolidated continuing operations key metrics compared to last year
- Revenues grew 34% to
$1.5 billion - Operating income rose 25% to
$200 million - Income from continuing operations fell 35% to
$14 million - Diluted earnings per share declined 50% to
$0.27
- Revenues grew 34% to
- Fourth quarter operating summary
- Hospital revenues rose 40%; same-store revenues increased 5% while admissions rose 4%
Medicare cuts materially hampered nursing center and rehabilitation therapy results- Home health and hospice business reported strong results
- Company continues to generate significant operating cash flows
- Excluding transaction-related payments, full year operating cash flows grew 11% to
$238 million
- Excluding transaction-related payments, full year operating cash flows grew 11% to
- Company reduces 2012 earnings guidance
RehabCare synergy estimate rises to$70 million from$62 million - Company expects to implement
$50 million to $55 million of additional cost reductions
- Company expects non-renewal of seven
Ventas bundles containing 64 facilities inApril 2013 - Future growth prospects for these facilities considered limited
- Many of the facilities do not align with the Company’s operating plan and cluster market strategy
- Expected 2013 EPS dilution of
$0.10 to $0.15 from these divestitures considered manageable - Divestitures will improve the Company’s capital structure over the long term
Fourth Quarter Results
Continuing Operations
Consolidated revenues for the fourth quarter ended
During the fourth quarter of 2011, the Company recorded approximately
Fiscal Year Results
Continuing Operations
Consolidated revenues for the year ended
Operating results in 2011 included asset impairment charges, transaction-related costs and a loss on a hospital divestiture that reduced income from continuing operations by
Management Commentary
Commenting on the Company’s liquidity and capital resources,
Earnings Guidance – Continuing Operations
The Company updated its earnings guidance for 2012. The earnings guidance provided by the Company excludes the effect of (i) any transaction-related charges, (ii) any other reimbursement changes, (iii) any acquisitions or divestitures, (iv) any impairment charges, or (v) any repurchases of common stock.
The Company expects consolidated revenues for 2012 to approximate
As a result of the significant volatility in its earnings in connection with recent changes in
The Company also indicated that it expects cash flows from operations in 2012 to range from
In addition, the Company continues its ongoing development of several previously announced projects. At
“Our fourth quarter operating results included the realization of approximately
Ventas Lease Renewals
Under its master lease agreements with
The Company intends to renew three renewal bundles containing 19 nursing and rehabilitation centers and six LTAC hospitals (collectively, the “Renewal Facilities”). The Renewal Facilities contain 2,178 licensed nursing and rehabilitation center beds and 616 licensed hospital beds and generated revenues of approximately
The Company also announced that it does not intend to renew seven renewal bundles containing 54 nursing and rehabilitation centers and ten LTAC hospitals (collectively, the “Expiring Facilities”). The Expiring Facilities contain 6,140 licensed nursing and rehabilitation center beds and 1,066 licensed hospital beds and generated revenues of approximately
Management believes that the divestiture of the Expiring Facilities could reduce the Company’s consolidated earnings per diluted share by
“As we have stated previously, we are focused on five key business strategies. First, we must be successful in our core operations by providing quality care and efficiently managing our costs. Second, we remain focused on accelerating our cluster market strategy both from an operational and capital investment perspective. In addition, we will continue to expand our home health and hospice operations. We also are active in developing new integrated care and payment models with other healthcare providers and payors that will be responsive to changes in the marketplace. Finally, we remain focused on re-deploying assets and management time to higher margin businesses. Exiting the Expiring Facilities is another significant step in our re-deployment strategy.”
The effectiveness of the renewals is contingent upon there being no event of default under the master lease agreements upon the renewal effective date in
Conference Call
As previously announced, investors and the general public may access a live webcast of the fourth quarter 2011 conference call through a link on the Company’s website at http://investors.kindredhealthcare.com or at www.earnings.com. The conference call will be held
A telephone replay of the conference call will become available at approximately
Forward-Looking Statements
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding the Company’s expected future financial position, results of operations, cash flows, financing plans, business strategy, budgets, capital expenditures, competitive positions, growth opportunities, plans and objectives of management and statements containing the words such as “anticipate,” “approximate,” “believe,” “plan,” “estimate,” “expect,” “project,” “could,” “should,” “will,” “intend,” “may” and other similar expressions, are forward-looking statements.
Such forward looking statements are inherently uncertain, and stockholders and other potential investors must recognize that actual results may differ materially from the Company’s expectations as a result of a variety of factors, including, without limitation, those discussed below. Such forward-looking statements are based upon management’s current expectations and include known and unknown risks, uncertainties and other factors, many of which the Company is unable to predict or control, that may cause the Company’s actual results or performance to differ materially from any future results or performance expressed or implied by such forward-looking statements. These statements involve risks, uncertainties and other factors discussed below and detailed from time to time in the Company’s filings with the
In addition to the factors set forth above, other factors that may affect the Company’s plans or results include, without limitation, (a) the impact of healthcare reform, which will initiate significant reforms to
In addition to the results provided in accordance with GAAP, the Company has provided non-GAAP measurements which present operating results and cash flows from operations for the fourth quarters and years ended
As noted above, the Company’s earnings release includes a financial measure referred to as operating income, or earnings before interest, income taxes, depreciation, amortization and rent. The Company’s management uses operating income as a meaningful measure of operational performance in addition to other measures. The Company uses operating income to assess the relative performance of its operating divisions as well as the employees that operate these businesses. In addition, the Company believes this measurement is important because securities analysts and investors use this measurement to compare the Company’s performance to other companies in the healthcare industry. The Company believes that income from continuing operations is the most comparable GAAP measure. Readers of the Company’s financial information should consider income from continuing operations as an important measure of the Company’s financial performance because it provides the most complete measure of its performance. Operating income should be considered in addition to, not as a substitute for, or superior to, financial measures based upon GAAP as an indicator of operating performance. A reconciliation of operating income to income from continuing operations provided in the Condensed Business Segment Data is included in this press release.
About
| Financial Summary | ||||||||||||||||||||
| (In thousands, except per share amounts) | ||||||||||||||||||||
| Three months ended | Year ended | |||||||||||||||||||
| December 31, | ||||||||||||||||||||
| 2011 | 2010 | 2011 | 2010 | |||||||||||||||||
| Revenues | $ | 1,522,688 | $ | 1,135,484 | $ | 5,521,763 | $ | 4,359,697 | ||||||||||||
| Income (loss) from continuing operations | $ | (72,914 | ) | $ | 19,755 | $ | (56,271 | ) | $ | 56,146 | ||||||||||
| Discontinued operations, net of income taxes: | ||||||||||||||||||||
| Income from operations | 1,025 | 1,125 | 2,552 | 798 | ||||||||||||||||
| Loss on divestiture of operations | - | (456 | ) | - | (453 | ) | ||||||||||||||
| Income from discontinued operations | 1,025 | 669 | 2,552 | 345 | ||||||||||||||||
| Net income (loss) | (71,889 | ) | 20,424 | (53,719 | ) | 56,491 | ||||||||||||||
| Loss attributable to noncontrolling interests | 58 | - | 238 | - | ||||||||||||||||
| Income (loss) attributable to Kindred | $ | (71,831 | ) | $ | 20,424 | $ | (53,481 | ) | $ | 56,491 | ||||||||||
| Amounts attributable to Kindred stockholders: | ||||||||||||||||||||
| Income (loss) from continuing operations | $ | (72,856 | ) | $ | 19,755 | $ | (56,033 | ) | $ | 56,146 | ||||||||||
| Income from discontinued operations | 1,025 | 669 | 2,552 | 345 | ||||||||||||||||
| Net income (loss) | $ | (71,831 | ) | $ | 20,424 | $ | (53,481 | ) | $ | 56,491 | ||||||||||
| Earnings (loss) per common share: | ||||||||||||||||||||
| Basic: | ||||||||||||||||||||
| Income (loss) from continuing operations | $ | (1.42 | ) | $ | 0.50 | $ | (1.21 | ) | $ | 1.42 | ||||||||||
| Discontinued operations: | ||||||||||||||||||||
| Income from operations | 0.02 | 0.03 | 0.05 | 0.02 | ||||||||||||||||
| Loss on divestiture of operations | - | (0.01 | ) | - | (0.01 | ) | ||||||||||||||
| Net income (loss) | $ | (1.40 | ) | $ | 0.52 | $ | (1.16 | ) | $ | 1.43 | ||||||||||
| Diluted: | ||||||||||||||||||||
| Income (loss) from continuing operations | $ | (1.42 | ) | $ | 0.50 | $ | (1.21 | ) | $ | 1.42 | ||||||||||
| Discontinued operations: | ||||||||||||||||||||
| Income from operations | 0.02 | 0.03 | 0.05 | 0.02 | ||||||||||||||||
| Loss on divestiture of operations | - | (0.01 | ) | - | (0.01 | ) | ||||||||||||||
| Net income (loss) | $ | (1.40 | ) | $ | 0.52 | $ | (1.16 | ) | $ | 1.43 | ||||||||||
|
Shares used in computing earnings (loss) per common share: |
||||||||||||||||||||
| Basic | 51,335 | 38,790 | 46,280 | 38,738 | ||||||||||||||||
| Diluted | 51,335 | 39,089 | 46,280 | 38,954 | ||||||||||||||||
| Condensed Consolidated Statement of Operations | ||||||||||||||||||||
| (In thousands, except per share amounts) | ||||||||||||||||||||
| Three months ended | Year ended | |||||||||||||||||||
| December 31, | ||||||||||||||||||||
| 2011 | 2010 | 2011 | 2010 | |||||||||||||||||
| Revenues | $ | 1,522,688 | $ | 1,135,484 | $ | 5,521,763 | $ | 4,359,697 | ||||||||||||
| Salaries, wages and benefits | 911,417 | 652,703 | 3,255,815 | 2,505,690 | ||||||||||||||||
| Supplies | 107,760 | 87,103 | 402,014 | 342,197 | ||||||||||||||||
| Rent | 106,616 | 90,777 | 399,257 | 357,372 | ||||||||||||||||
| Other operating expenses | 312,674 | 240,750 | 1,164,480 | 948,609 | ||||||||||||||||
| Other income | (2,711 | ) | (2,687 | ) | (11,191 | ) | (11,422 | ) | ||||||||||||
| Impairment charges | 102,569 | - | 129,281 | - | ||||||||||||||||
| Depreciation and amortization | 48,227 | 31,412 | 165,594 | 121,552 | ||||||||||||||||
| Interest expense | 26,244 | 2,843 | 80,919 | 7,090 | ||||||||||||||||
| Investment income | (242 | ) | (342 | ) | (1,031 | ) | (1,245 | ) | ||||||||||||
| 1,612,554 | 1,102,559 | 5,585,138 | 4,269,843 | |||||||||||||||||
| Income (loss) from continuing operations before income taxes | (89,866 | ) | 32,925 | (63,375 | ) | 89,854 | ||||||||||||||
| Provision (benefit) for income taxes | (16,952 | ) | 13,170 | (7,104 | ) | 33,708 | ||||||||||||||
| Income (loss) from continuing operations | (72,914 | ) | 19,755 | (56,271 | ) | 56,146 | ||||||||||||||
| Discontinued operations, net of income taxes: | ||||||||||||||||||||
| Income from operations | 1,025 | 1,125 | 2,552 | 798 | ||||||||||||||||
| Loss on divestiture of operations | - | (456 | ) | - | (453 | ) | ||||||||||||||
| Income from discontinued operations | 1,025 | 669 | 2,552 | 345 | ||||||||||||||||
| Net income (loss) | (71,889 | ) | 20,424 | (53,719 | ) | 56,491 | ||||||||||||||
| Loss attributable to noncontrolling interests | 58 | - | 238 | - | ||||||||||||||||
| Income (loss) attributable to Kindred | $ | (71,831 | ) | $ | 20,424 | $ | (53,481 | ) | $ | 56,491 | ||||||||||
| Amounts attributable to Kindred stockholders: | ||||||||||||||||||||
| Income (loss) from continuing operations | $ | (72,856 | ) | $ | 19,755 | $ | (56,033 | ) | $ | 56,146 | ||||||||||
| Income from discontinued operations | 1,025 | 669 | 2,552 | 345 | ||||||||||||||||
| Net income (loss) | $ | (71,831 | ) | $ | 20,424 | $ | (53,481 | ) | $ | 56,491 | ||||||||||
| Earnings (loss) per common share: | ||||||||||||||||||||
| Basic: | ||||||||||||||||||||
| Income (loss) from continuing operations | $ | (1.42 | )</td> | $ | 0.50 | $ | (1.21 | ) | $ | 1.42 | ||||||||||
| Discontinued operations: | ||||||||||||||||||||
| Income from operations | 0.02 | 0.03 | 0.05 | 0.02 | ||||||||||||||||
| Loss on divestiture of operations | - | (0.01 | ) | - | (0.01 | ) | ||||||||||||||
| Net income (loss) | $ | (1.40 | ) | $ | 0.52 | $ | (1.16 | ) | $ | 1.43 | ||||||||||
| Diluted: | ||||||||||||||||||||
| Income (loss) from continuing operations | $ | (1.42 | ) | $ | 0.50 | $ | (1.21 | ) | $ | 1.42 | ||||||||||
| Discontinued operations: | ||||||||||||||||||||
| Income from operations | 0.02 | 0.03 | 0.05 | 0.02 | ||||||||||||||||
| Loss on divestiture of operations | - | (0.01 | ) | - | (0.01 | ) | ||||||||||||||
| Net income (loss) | $ | (1.40 | ) | $ | 0.52 | $ | (1.16 | ) | $ | 1.43 | ||||||||||
|
Shares used in computing earnings (loss) per common share: |
||||||||||||||||||||
| Basic | 51,335 | 38,790 | 46,280 | 38,738 | ||||||||||||||||
| Diluted | 51,335 | 39,089 | 46,280 | 38,954 | ||||||||||||||||
| Condensed Consolidated Balance Sheet | ||||||||||
| (In thousands, except per share amounts) | ||||||||||
| December 31, | ||||||||||
| 2011 | 2010 | |||||||||
| ASSETS | ||||||||||
| Current assets: | ||||||||||
| Cash and cash equivalents | $ | 41,561 | $ | 17,168 | ||||||
| Cash - restricted | 5,551 | 5,494 | ||||||||
| Insurance subsidiary investments | 70,425 | 76,753 | ||||||||
| Accounts receivable less allowance for loss | 994,700 | 631,877 | ||||||||
| Inventories | 31,060 | 24,327 | ||||||||
| Deferred tax assets | 17,785 | 13,439 | ||||||||
| Income taxes | 39,513 | 42,118 | ||||||||
| Other | 32,687 | 24,862 | ||||||||
| 1,233,282 | 836,038 | |||||||||
| Property and equipment | 1,975,063 | 1,754,170 | ||||||||
| Accumulated depreciation | (916,022 | ) | (857,623 | ) | ||||||
| 1,059,041 | 896,547 | |||||||||
| Goodwill | 1,084,655 | 242,420 | ||||||||
| Intangible assets less accumulated amortization | 447,207 | 92,883 | ||||||||
| Assets held for sale | 5,612 | 7,167 | ||||||||
| Insurance subsidiary investments | 110,227 | 101,210 | ||||||||
| Deferred tax assets | - | 88,816 | ||||||||
| Other | 198,469 | 72,334 | ||||||||
| Total assets | $ | 4,138,493 | $ | 2,337,415 | ||||||
| LIABILITIES AND EQUITY | ||||||||||
| Current liabilities: | ||||||||||
| Accounts payable | $ | 216,801 | $ | 174,495 | ||||||
| Salaries, wages and other compensation | 407,493 | 291,116 | ||||||||
| Due to third party payors | 37,306 | 27,115 | ||||||||
| Professional liability risks | 46,010 | 41,555 | ||||||||
| Other accrued liabilities | 130,693 | 87,012 | ||||||||
| Long-term debt due within one year | 10,620 | 91 | ||||||||
| 848,923 | 621,384 | |||||||||
| Long-term debt | 1,531,882 | 365,556 | ||||||||
| Professional liability risks | 217,717 | 207,669 | ||||||||
| Deferred tax liabilities | 17,955 | - | ||||||||
| Deferred credits and other liabilities | 191,771 | 111,047 | ||||||||
| Noncontrolling interests-redeemable | 9,704 | - | ||||||||
| Equity: | ||||||||||
| Stockholders' equity: | ||||||||||
|
Common stock, |
13,029 | 9,874 | ||||||||
| Capital in excess of par value | 1,138,189 | 828,593 | ||||||||
| Accumulated other comprehensive income (loss) | (1,469 | ) | 135 | |||||||
| Retained earnings | 139,172 | 193,157 | ||||||||
| 1,288,921 | 1,031,759 | |||||||||
| Noncontrolling interests-nonredeemable | 31,620 | - | ||||||||
| Total equity | 1,320,541 | 1,031,759 | ||||||||
| Total liabilities and equity | $ | 4,138,493 | $ | 2,337,415 | ||||||
| Condensed Consolidated Statement of Cash Flows | ||||||||||||||||||||
| (In thousands) | ||||||||||||||||||||
| Three months ended | Year ended | |||||||||||||||||||
| December 31, | ||||||||||||||||||||
| 2011 | 2010 | 2011 | 2010 | |||||||||||||||||
| Cash flows from operating activities: | ||||||||||||||||||||
| Net income (loss) | $ | (71,889 | ) | $ | 20,424 | $ | (53,719 | ) | $ | 56,491 | ||||||||||
|
Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
||||||||||||||||||||
| Depreciation and amortization | 48,227 | 31,412 | 165,594 | 121,552 | ||||||||||||||||
| Amortization of stock-based compensation costs | 3,208 | 2,600 | 12,819 | 10,714 | ||||||||||||||||
| Payment of lender fees related to debt issuance | - | - | (46,232 | ) | - | |||||||||||||||
| Provision for doubtful accounts | 13,084 | 6,010 | 35,133 | 24,397 | ||||||||||||||||
| Deferred income taxes | 5,170 | 35,190 | 195 | 21,446 | ||||||||||||||||
| Impairment charges | 102,569 | - | 129,281 | - | ||||||||||||||||
| Loss on divestiture of discontinued operations | - | 456 | - | 453 | ||||||||||||||||
| Other | 4,053 | 2,118 | 5,518 | 252 | ||||||||||||||||
| Change in operating assets and liabilities: | ||||||||||||||||||||
| Accounts receivable | (36,758 | ) | (23,853 | ) | (144,830 | ) | (45,232 | ) | ||||||||||||
| Inventories and other assets | (4,451 | ) | (6,720 | ) | (802 | ) | (14,294 | ) | ||||||||||||
| Accounts payable | 299 | 25,139 | 685 | 9,446 | ||||||||||||||||
| Income taxes | (25,537 | ) | (22,272 | ) | (4,745 | ) | 3,462 | |||||||||||||
| Due to third party payors | (4,130 | ) | (8,886 | ) | 568 | 1,213 | ||||||||||||||
| Other accrued liabilities | 2,055 | (2,485 | ) | 54,241 | 20,088 | |||||||||||||||
| Net cash provided by operating activities | 35,900 | 59,133 | 153,706 | 209,988 | ||||||||||||||||
| Cash flows from investing activities: | ||||||||||||||||||||
| Routine capital expenditures | (37,640 | ) | (39,788 | ) | (132,903 | ) | (108,896 | ) | ||||||||||||
| Development capital expenditures | (18,085 | ) | (27,622 | ) | (87,655 | ) | (67,841 | ) | ||||||||||||
| Acquisitions, net of cash acquired | (4,551 | ) | (191,925 | ) | (715,458 | ) | (279,794 | ) | ||||||||||||
| Sale of assets | - | 649 | 1,714 | 649 | ||||||||||||||||
| Purchase of insurance subsidiary investments | (9,719 | ) | (9,229 | ) | (35,623 | ) | (43,913 | ) | ||||||||||||
| Sale of insurance subsidiary investments | 8,720 | 9,765 | 46,307 | 82,736 | ||||||||||||||||
|
Net change in insurance subsidiary cash and cash equivalents |
(9,343 | ) | 2,091 | (14,213 | ) | (8,521 | ) | |||||||||||||
| Change in other investments | 3 | - | 1,003 | 2 | ||||||||||||||||
| Other | 180 | (317 | ) | (512 | ) | 962 | ||||||||||||||
| Net cash used in investing activities | (70,435 | ) | (256,376 | ) | (937,340 | ) | (424,616 | ) | ||||||||||||
| Cash flows from financing activities: | ||||||||||||||||||||
| Proceeds from borrowings under revolving credit | 493,500 | 920,900 | 2,126,800 | 2,030,800 | ||||||||||||||||
| Repayment of borrowings under revolving credit | (448,500 | ) | (720,400 | ) | (2,198,300 | ) | (1,812,800 | ) | ||||||||||||
| Proceeds from issuance of senior unsecured notes | - | - | 550,000 | - | ||||||||||||||||
| Proceeds from issuance of term loan, net of discount | - | - | 693,000 | - | ||||||||||||||||
| Repayment of other long-term debt | (2,645 | ) | (22 | ) | (350,878 | ) | (86 | ) | ||||||||||||
| Payment of deferred financing costs | (383 | ) | (1,417 | ) | (9,098 | ) | (2,831 | ) | ||||||||||||
| Issuance of common stock | - | 14 | 3,019 | 49 | ||||||||||||||||
| Purchase of noncontrolling interests in subsidiaries | - | - | (7,292 | ) | - | |||||||||||||||
| Other | 29 | 15 | 776 | 361 | ||||||||||||||||
| Net cash provided by financing activities | 42,001 | 199,090 | 808,027 | 215,493 | ||||||||||||||||
| Change in cash and cash equivalents | 7,466 | 1,847 | 24,393 | 865 | ||||||||||||||||
| Cash and cash equivalents at beginning of period | 34,095 | 15,321 | 17,168 | 16,303 | ||||||||||||||||
| Cash and cash equivalents at end of period | $ | 41,561 | $ | 17,168 | $ | 41,561 | $ | 17,168 | ||||||||||||
| Condensed Consolidated Statement of Operations | ||||||||||||||||||||||||||||||||||||||||||||||||||
| (In thousands, except per share amounts) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| 2010 Quarters | 2011 Quarters | |||||||||||||||||||||||||||||||||||||||||||||||||
| First | Second | Third | Fourth | Year | First | Second | Third | Fourth | Year | |||||||||||||||||||||||||||||||||||||||||
| Revenues | $ | 1,089,837 | $ | 1,081,364 | $ | 1,053,012 | $ | 1,135,484 | $ | 4,359,697 | $ | 1,192,421 | $ | 1,292,592 | $ | 1,514,062 | $ | 1,522,688 | $ | 5,521,763 | ||||||||||||||||||||||||||||||
| Salaries, wages and benefits | 627,175 | 612,205 | 613,607 | 652,703 | 2,505,690 | 678,695 | 765,133 | 900,570 | 911,417 | 3,255,815 | ||||||||||||||||||||||||||||||||||||||||
| Supplies | 85,886 | 85,455 | 83,753 | 87,103 | 342,197 | 90,022 | 96,718 | 107,514 | 107,760 | 402,014 | ||||||||||||||||||||||||||||||||||||||||
| Rent | 88,319 | 88,981 | 89,295 | 90,777 | 357,372 | 91,453 | 95,677 | 105,511 | 106,616 | 399,257 | ||||||||||||||||||||||||||||||||||||||||
| Other operating expenses | 234,204 | 238,687 | 234,968 | 240,750 | 948,609 | 259,369 | 287,132 | 305,305 | 312,674 | 1,164,480 | ||||||||||||||||||||||||||||||||||||||||
| Other income | (3,084 | ) | (2,857 | ) | (2,794 | ) | (2,687 | ) | (11,422 | ) | (2,785 | ) | (2,880 | ) | (2,815 | ) | (2,711 | ) | (11,191 | ) | ||||||||||||||||||||||||||||||
| Impairment charges | - | - | - | - | - | - | - | 26,712 | 102,569 | 129,281 | ||||||||||||||||||||||||||||||||||||||||
| Depreciation and amortization | 31,121 | 29,852 | 29,167 | 31,412 | 121,552 | 32,549 | 37,871 | 46,947 | 48,227 | 165,594 | ||||||||||||||||||||||||||||||||||||||||
| Interest expense | 1,307 | 1,298 | 2,843 | 7,090 | 5,728 | 23,157 | 25,790 | 26,244 | 80,919 | |||||||||||||||||||||||||||||||||||||||||
| Investment (income) loss | (877 | ) | 377 | (403 | ) | (342 | ) | (1,245 | ) | (495 | ) | (257 | ) | (37 | ) | (242 | ) | (1,031 | ) | |||||||||||||||||||||||||||||||
| 1,064,051 | 1,053,998 | 1,049,235 | 1,102,559 | 4,269,843 | 1,154,536 | 1,302,551 | 1,515,497 | 1,612,554 | 5,585,138 | |||||||||||||||||||||||||||||||||||||||||
|
Income (loss) from continuing operations before income taxes |
25,786 | 27,366 | 3,777 | 32,925 | 89,854 | 37,885 | (9,959 | ) | (1,435 | ) | (89,866 | ) | (63,375 | ) | ||||||||||||||||||||||||||||||||||||
| Provision (benefit) for income taxes | 10,631 | 11,230 | (1,323 | ) | 13,170 | 33,708 | 15,609 | (3,419 | ) | (2,342 | ) | (16,952 | ) | (7,104 | ) | |||||||||||||||||||||||||||||||||||
| Income (loss) from continuing operations | 15,155 | 16,136 | 5,100 | 19,755 | 56,146 | 22,276 | (6,540 | ) | 907 | (72,914 | ) | (56,271 | ) | |||||||||||||||||||||||||||||||||||||
| Discontinued operations, net of income taxes: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Income (loss) from operations | (154 | ) | 87 | (260 | ) | 1,125 | 798 | (179 | ) | 587 | 1,119 | 1,025 | 2,552 | |||||||||||||||||||||||||||||||||||||
| Gain (loss) on divestiture of operations | (137 | ) | 54 | 86 | (456 | ) | (453 | ) | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||
| Income (loss) from discontinued operations | (291 | ) | 141 | (174 | ) | 669 | 345 | (179 | ) | 587 | 1,119 | 1,025 | 2,552 | |||||||||||||||||||||||||||||||||||||
| Net income (loss) | 14,864 | 16,277 | 4,926 | 20,424 | 56,491 | 22,097 | (5,953 | ) | 2,026 | (71,889 | ) | (53,719 | ) | |||||||||||||||||||||||||||||||||||||
|
(Earnings) loss attributable to noncontrolling interests |
- | - | - | - | - | - | 421 | (241 | ) | 58 | 238 | |||||||||||||||||||||||||||||||||||||||
| Income (loss) attributable to Kindred | $ | 14,864 | $ | 16,277 | $ | 4,926 | $ | 20,424 | $ | 56,491 | $ | 22,097 | $ | (5,532 | ) | $ | 1,785 | $ | (71,831 | ) | $ | (53,481 | ) | |||||||||||||||||||||||||||
| Amounts attributable to Kindred stockholders: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Income (loss) from continuing operations | $ | 15,155 | $ | 16,136 | $ | 5,100 | $ | 19,755 | $ | 56,146 | $ | 22,276 | $ | (6,119 | ) | $ | 666 | $ | (72,856 | ) | $ | (56,033 | ) | |||||||||||||||||||||||||||
| Income (loss) from discontinued operations | (291 | ) | 141 | (174 | ) | 669 | 345 | (179 | ) | 587 | 1,119 | 1,025 | 2,552 | |||||||||||||||||||||||||||||||||||||
| Net income (loss) | $ | 14,864 | $ | 16,277 | $ | 4,926 | $ | 20,424 | $ | 56,491 | $ | 22,097 | $ | (5,532 | ) | $ | 1,785 | $ | (71,831 | ) | $ | (53,481 | ) | |||||||||||||||||||||||||||
| Earnings (loss) per common share: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Basic: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Income (loss) from continuing operations | $ | 0.38 | $ | 0.41 | $ | 0.13 | $ | 0.50 | $ | 1.42 | $ | 0.56 | $ | (0.14 | ) | $ | 0.01 | $ | (1.42 | ) | $ | (1.21 | ) | |||||||||||||||||||||||||||
| Discontinued operations: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Income (loss) from operations | - | - | (0.01 | ) | 0.03 | 0.02 | - | 0.01 | 0.02 | 0.02 | 0.05 | |||||||||||||||||||||||||||||||||||||||
| Gain (loss) on divestiture of operations | - | - | - | (0.01 | ) | (0.01 | ) | - | - | - | - | - | ||||||||||||||||||||||||||||||||||||||
| Net income (loss) | $ | 0.38 | $ | 0.41 | $ | 0.12 | $ | 0.52 | $ | 1.43 | $ | 0.56 | $ | (0.13 | ) | $ | 0.03 | $ | (1.40 | ) | $ | (1.16 | ) | |||||||||||||||||||||||||||
| Diluted: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Income (loss) from continuing operations | $ | 0.38 | $ | 0.41 | $ | 0.13 | $ | 0.50 | $ | 1.42 | $ | 0.55 | $ | (0.14 | ) | $ | 0.01 | $ | (1.42 | ) | $ | (1.21 | ) | |||||||||||||||||||||||||||
| Discontinued operations: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Income (loss) from operations | - | - | (0.01 | ) | 0.03 | 0.02 | - | 0.01 | 0.02 | 0.02 | 0.05 | |||||||||||||||||||||||||||||||||||||||
| Gain (loss) on divestiture of operations | - | - | - | (0.01 | ) | (0.01 | ) | - | - | - | - | - | ||||||||||||||||||||||||||||||||||||||
| Net income (loss) | $ | 0.38 | $ | 0.41 | $ | 0.12 | $ | 0.52 | $ | 1.43 | $ | 0.55 | $ | (0.13 | ) | $ | 0.03 | $ | (1.40 | ) | $ | (1.16 | ) | |||||||||||||||||||||||||||
|
Shares used in computing earnings (loss) per common share: |
||||||||||||||||||||||||||||||||||||||||||||||||||
| Basic | 38,626 | 38,756 | 38,778 | 38,790 | 38,738 | 39,035 | 43,231 | 51,329 | 51,335 | 46,280 | ||||||||||||||||||||||||||||||||||||||||
| Diluted | 38,859 | 38,914 | 38,838 | 39,089 | 38,954 | 39,543 | 43,231 | 51,406 | 51,335 | 46,280 | ||||||||||||||||||||||||||||||||||||||||
| Condensed Business Segment Data | |||||||||||||||||||||||||||||||||||||||||||||||||||
| (In thousands) | |||||||||||||||||||||||||||||||||||||||||||||||||||
| 2010 Quarters | 2011 Quarters | ||||||||||||||||||||||||||||||||||||||||||||||||||
| First | Second | Third | Fourth | Year | First | Second | Third | Fourth | Year | ||||||||||||||||||||||||||||||||||||||||||
| Revenues: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Hospital division | $ | 507,062 | $ | 493,401 | $ | 465,198 | $ | 507,660 | $ | 1,973,321 | $ | 558,974 | $ | 593,425 | $ | 684,781 | $ | 712,812 | $ | 2,549,992 | |||||||||||||||||||||||||||||||
| Nursing center division | 539,321 | 542,215 | 539,914 | 566,435 | 2,187,885 | 567,472 | 568,199 | 571,226 | 547,202 | 2,254,099 | |||||||||||||||||||||||||||||||||||||||||
| Rehabilitation division: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Skilled nursing rehabilitation services | 95,563 | 97,273 | 99,860 | 111,059 | 403,755 | 114,618 | 161,246 | 252,574 | 246,720 | 775,158 | |||||||||||||||||||||||||||||||||||||||||
| Hospital rehabilitation services | 21,147 | 20,913 | 20,436 | 21,182 | 83,678 | 22,490 | 38,291 | 69,811 | 70,232 | 200,824 | |||||||||||||||||||||||||||||||||||||||||
| 116,710 | 118,186 | 120,296 | 132,241 | 487,433 | 137,108 | 199,537 | 322,385 | 316,952 | 975,982 | ||||||||||||||||||||||||||||||||||||||||||
| Home health and hospice division | 3,434 | 3,875 | 3,947 | 6,266 | 17,522 | 8,038 | 10,828 | 15,419 | 26,451 | 60,736 | |||||||||||||||||||||||||||||||||||||||||
| 1,166,527 | 1,157,677 | 1,129,355 | 1,212,602 | 4,666,161 | 1,271,592 | 1,371,989 | 1,593,811 | 1,603,417 | 5,840,809 | ||||||||||||||||||||||||||||||||||||||||||
| Eliminations: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Skilled nursing rehabilitation services | (56,127 | ) | (55,809 | ) | (56,323 | ) | (56,365 | ) | (224,624 | ) | (57,081 | ) | (57,587 | ) | (57,922 | ) | (57,087 | ) | (229,677 | ) | |||||||||||||||||||||||||||||||
| Hospital rehabilitation services | (20,226 | ) | (20,034 | ) | (19,502 | ) | (20,034 | ) | (79,796 | ) | (21,225 | ) | (20,706 | ) | (20,528 | ) | (22,167 | ) | (84,626 | ) | |||||||||||||||||||||||||||||||
| Home health and hospice | (337 | ) | (470 | ) | (518 | ) | (719 | ) | (2,044 | ) | (865 | ) | (1,104 | ) | (1,299 | ) | (1,475 | ) | (4,743 | ) | |||||||||||||||||||||||||||||||
| (76,690 | ) | (76,313 | ) | (76,343 | ) | (77,118 | ) | (306,464 | ) | (79,171 | ) | (79,397 | ) | (79,749 | ) | (80,729 | ) | (319,046 | ) | ||||||||||||||||||||||||||||||||
| $ | 1,089,837 | $ | 1,081,364 | $ | 1,053,012 | $ | 1,135,484 | $ | 4,359,697 | $ | 1,192,421 | $ | 1,292,592 | $ | 1,514,062 | $ | 1,522,688 | $ | 5,521,763 | ||||||||||||||||||||||||||||||||
| Income (loss) from continuing operations: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Operating income (loss): | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Hospital division | $ | 95,440 | $ | 91,790 | $ | 75,784 | $ | 97,343 | $ | 360,357 | $ | 108,385 | $ | 108,465 | $ | 125,701 | $ | 144,891 | (a) | $ | 487,442 | ||||||||||||||||||||||||||||||
| Nursing center division | 70,614 | 76,529 | 69,363 | 86,912 | 303,418 | 87,350 | 93,532 | 89,592 | 67,791 | 338,265 | |||||||||||||||||||||||||||||||||||||||||
| Rehabilitation division: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Skilled nursing rehabilitation services | 9,575 | 9,325 | 9,580 | 5,223 | 33,703 | 9,159 | 15,978 | 27,575 | 13,204 | 65,916 | |||||||||||||||||||||||||||||||||||||||||
| Hospital rehabilitation services | 5,146 | 4,793 | 4,728 | 4,302 | 18,969 | 5,332 | 8,033 | 15,606 | 14,760 | 43,731 | |||||||||||||||||||||||||||||||||||||||||
| 14,721 | 14,118 | 14,308 | 9,525 | 52,672 | 14,491 | 24,011 | 43,181 | 27,964 | 109,647 | ||||||||||||||||||||||||||||||||||||||||||
| Home health and hospice division | (38 | ) | (18 | ) | (94 | ) | 84 | (66 | ) | (10 | ) | (447 | ) | 1,107 | 2,453 | 3,103 | |||||||||||||||||||||||||||||||||||
| Corporate: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Overhead | (33,831 | ) | (32,799 | ) | (34,329 | ) | (33,002 | ) | (133,961 | ) | (38,315 | ) | (43,801 | ) | (48,806 | ) | (43,878 | ) | (174,800 | ) | |||||||||||||||||||||||||||||||
| Insurance subsidiary | (480 | ) | (791 | ) | (783 | ) | (1,099 | ) | (3,153 | ) | (602 | ) | (420 | ) | (750 | ) | (534 | ) | (2,306 | ) | |||||||||||||||||||||||||||||||
| (34,311 | ) | (33,590 | ) | (35,112 | ) | (34,101 | ) | (137,114 | ) | (38,917 | ) | (44,221 | ) | (49,556 | ) | (44,412 | ) | (177,106 | ) | ||||||||||||||||||||||||||||||||
| Impairment charges (b) | - | - | - | - | - | - | - | (26,712 | ) | (102,569 | ) | (129,281 | ) | ||||||||||||||||||||||||||||||||||||||
| Transaction costs (c) | (770 | ) | (955 | ) | (771 | ) | (2,148 | ) | (4,644 | ) | (4,179 | ) | (34,851 | ) | (6,537 | ) | (5,139 | ) | (50,706 | ) | |||||||||||||||||||||||||||||||
| Operating income | 145,656 | 147,874 | 123,478 | 157,615 | 574,623 | 167,120 | 146,489 | 176,776 | 90,979 | 581,364 | |||||||||||||||||||||||||||||||||||||||||
| Rent | (88,319 | ) | (88,981 | ) | (89,295 | ) | (90,777 | ) | (357,372 | ) | (91,453 | ) | (95,677 | ) | (105,511 | ) | (106,616 | ) | (d) | (399,257 | ) | ||||||||||||||||||||||||||||||
| Depreciation and amortization | (31,121 | ) | (29,852 | ) | (29,167 | ) | (31,412 | ) | (121,552 | ) | (32,549 | ) | (37,871 | ) | (46,947 | ) | (48,227 | ) | (165,594 | ) | |||||||||||||||||||||||||||||||
| Interest, net | (430 | ) | (1,675 | ) | (1,239 | ) | (2,501 | ) | (5,845 | ) | (5,233 | ) | (22,900 | ) | (25,753 | ) | (26,002 | ) | (79,888 | ) | |||||||||||||||||||||||||||||||
|
Income (loss) from continuing operations before income taxes |
25,786 | 27,366 | 3,777 | 32,925 | 89,854 | 37,885 | (9,959 | ) | (1,435 | ) | (89,866 | ) | (63,375 | ) | |||||||||||||||||||||||||||||||||||||
| Provision (benefit) for income taxes | 10,631 | 11,230 | (1,323 | ) | 13,170 | 33,708 | 15,609 | (3,419 | ) | (2,342 | ) | (16,952 | ) | (7,104 | ) | ||||||||||||||||||||||||||||||||||||
| $ | 15,155 | $ | 16,136 | $ | 5,100 | $ | 19,755 | $ | 56,146 | $ | 22,276 | $ | (6,540 | ) | $ | 907 | $ | (72,914 | ) | $ | (56,271 | ) | |||||||||||||||||||||||||||||
| (a) Includes loss on divestiture of a hospital of |
|||||||||||||||||||||||||||||||||||||||||||||||||||
| (b) Impairment charges for the third quarter of 2011 have been reclassified to conform with the current period presentation. | |||||||||||||||||||||||||||||||||||||||||||||||||||
| (c) Transaction costs for the 2010 periods have been reclassified to conform with the current period presentation. | |||||||||||||||||||||||||||||||||||||||||||||||||||
| (d) Includes lease cancellation charge of |
|||||||||||||||||||||||||||||||||||||||||||||||||||
| Condensed Consolidating Statement of Operations | |||||||||||||||||||||||||||||||||||||||||||||||||
| (In thousands) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Three months ended |
|||||||||||||||||||||||||||||||||||||||||||||||||
| Nursing | Rehabilitation division | Home | Transaction- | ||||||||||||||||||||||||||||||||||||||||||||||
| Hospital | center | Skilled nursing</td> | Hospital | health and | related | ||||||||||||||||||||||||||||||||||||||||||||
| division (a) | division | services | services | Total | hospice | Corporate | costs | Eliminations | Consolidated | ||||||||||||||||||||||||||||||||||||||||
| Revenues | $ | 712,812 | $ | 547,202 | $ | 246,720 | $ | 70,232 | $ | 316,952 | $ | 26,451 | $ | - | $ | - | $ | (80,729 | ) | $ | 1,522,688 | ||||||||||||||||||||||||||||
| Salaries, wages and benefits | 321,657 | 269,454 | 221,404 | 50,151 | 271,555 | 19,155 | 28,976 | 647 | (27 | ) | 911,417 | ||||||||||||||||||||||||||||||||||||||
| Supplies | 77,124 | 28,450 | 843 | 67 | 910 | 1,025 | 251 | - | - | 107,760 | |||||||||||||||||||||||||||||||||||||||
| Rent | 52,299 | 49,748 | 1,415 | 72 | 1,487 | 568 | 695 | 1,819 | - | 106,616 | |||||||||||||||||||||||||||||||||||||||
| Other operating expenses | 169,140 | 181,507 | 11,269 | 5,254 | 16,523 | 3,818 | 17,896 | 4,492 | (80,702 | ) | 312,674 | ||||||||||||||||||||||||||||||||||||||
| Other income | - | - | - | - | - | - | (2,711 | ) | - | - | (2,711 | ) | |||||||||||||||||||||||||||||||||||||
| 54,325 | 2,245 | 45,999 | - | 45,999 | - | - | 102,569 | ||||||||||||||||||||||||||||||||||||||||||
| Depreciation and amortization | 22,448 | 12,554 | 2,617 | 2,349 | 4,966 | 902 | 7,357 | - | - | 48,227 | |||||||||||||||||||||||||||||||||||||||
| Interest expense | 228 | 26 | - | - | - | 1 | 25,989 | - | - | 26,244 | |||||||||||||||||||||||||||||||||||||||
| Investment income | (3 | ) | (28 | ) | - | - | - | (1 | ) | (210 | ) | - | - | (242 | ) | ||||||||||||||||||||||||||||||||||
| 697,218 | 543,956 | 283,547 | 57,893 | 341,440 | 25,468 | 78,243 | 6,958 | (80,729 | ) | 1,612,554 | |||||||||||||||||||||||||||||||||||||||
|
Income (loss) from continuing operations before income taxes |
$ | 15,594 | $ | 3,246 | $ | (36,827 | ) | $ | 12,339 | $ | (24,488 | ) | $ | 983 | $ | (78,243 | ) | $ | (6,958 | ) | $ | - | (89,866 | ) | |||||||||||||||||||||||||
| Income tax benefit | (16,952 | ) | |||||||||||||||||||||||||||||||||||||||||||||||
| Loss from continuing operations | $ | (72,914 | ) | ||||||||||||||||||||||||||||||||||||||||||||||
|
Capital expenditures, excluding acquisitions (including discontinued operations): |
|||||||||||||||||||||||||||||||||||||||||||||||||
| Routine | $ | 9,521 | $ | 7,577 | $ | 1,031 | $ | 60 | $ | 1,091 | $ | 65 | $ | 19,386 | $ | - | $ | - | $ | 37,640 | |||||||||||||||||||||||||||||
| Development | 13,157 | 4,027 | - | - | - | 901 | - | - | - | 18,085 | |||||||||||||||||||||||||||||||||||||||
| $ | 22,678 | $ | 11,604 | $ | 1,031 | $ | 60 | $ | 1,091 | $ | 966 | $ | 19,386 | $ | - | $ | - | $ | 55,725 | ||||||||||||||||||||||||||||||
| Three months ended |
|||||||||||||||||||||||||||||||||||||||||||||||||
| Nursing | Rehabilitation division | Home | Transaction- | ||||||||||||||||||||||||||||||||||||||||||||||
| Hospital | center | Skilled nursing | Hospital | health and | related | ||||||||||||||||||||||||||||||||||||||||||||
| division | division | services | services | Total | hospice | Corporate | costs | Eliminations | Consolidated | ||||||||||||||||||||||||||||||||||||||||
| Revenues | $ | 507,660 | $ | 566,435 | $ | 111,059 | </td> | $ | 21,182 | $ | 132,241 | $ | 6,266 | $ | - | $ | - | $ | (77,118 | ) | $ | 1,135,484 | |||||||||||||||||||||||||||
| Salaries, wages and benefits | 230,028 | 274,784 | 102,835 | 16,213 | 119,048 | 4,719 | 23,813 | 357 | (46 | ) | 652,703 | ||||||||||||||||||||||||||||||||||||||
| Supplies | 57,884 | 28,131 | 573 | 39 | 612 | 332 | 144 | - | - | 87,103 | |||||||||||||||||||||||||||||||||||||||
| Rent | 39,406 | 49,647 | 1,540 | 27 | 1,567 | 122 | 35 | - | - | 90,777 | |||||||||||||||||||||||||||||||||||||||
| Other operating expenses | 122,405 | 176,608 | 2,428 | 628 | 3,056 | 1,131 | 12,831 | 1,791 | (77,072 | ) | 240,750 | ||||||||||||||||||||||||||||||||||||||
| Other income | - | - | - | - | - | - | (2,687 | ) | - | - | (2,687 | ) | |||||||||||||||||||||||||||||||||||||
| Depreciation and amortization | 13,421 | 11,646 | 646 | 99 | 745 | 85 | 5,515 | - | - | 31,412 | |||||||||||||||||||||||||||||||||||||||
| Interest expense | 2 | 35 | - | - | - | - | 2,806 | - | - | 2,843 | |||||||||||||||||||||||||||||||||||||||
| Investment income | (2 | ) | (14 | ) | (2 | ) | - | (2 | ) | - | (324 | ) | - | - | (342 | ) | |||||||||||||||||||||||||||||||||
| 463,144 | 540,837 | 108,020 | 17,006 | 125,026 | 6,389 | 42,133 | 2,148 | (77,118 | ) | 1,102,559 | |||||||||||||||||||||||||||||||||||||||
|
Income (loss) from continuing operations before income taxes |
$ | 44,516 | $ | 25,598 | $ | 3,039 | $ | 4,176 | $ | 7,215 | $ | (123 | ) | $ | (42,133 | ) | $ | (2,148 | ) | $ | - | 32,925 | |||||||||||||||||||||||||||
| Provision for income taxes | 13,170 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Income from continuing operations | $ | 19,755 | |||||||||||||||||||||||||||||||||||||||||||||||
|
Capital expenditures, excluding acquisitions (including discontinued operations): |
|||||||||||||||||||||||||||||||||||||||||||||||||
| Routine | $ | 13,835 | $ | 12,292 | $ | 1,547 | $ | 208 | $ | 1,755 | $ | 61 | $ | 11,845 | $ | - | $ | - | $ | 39,788 | |||||||||||||||||||||||||||||
| Development | 12,257 | 15,365 | - | - | - | - | - | - | - | 27,622 </td> | |||||||||||||||||||||||||||||||||||||||
| $ | 26,092 | $ | 27,657 | $ | 1,547 | $ | 208 | $ | 1,755 | $ | 61 | $ | 11,845 | $ | - | $ | - | $ | 67,410 | ||||||||||||||||||||||||||||||
|
(a) Includes loss on divestiture of a hospital of |
|||||||||||||||||||||||||||||||||||||||||||||||||
| Condensed Consolidating Statement of Operations | ||||||||||||||||||||||||||||||||||||||||||||||||||
| (In thousands) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Year ended |
||||||||||||||||||||||||||||||||||||||||||||||||||
| Nursing | Rehabilitation division | Home | Transaction- | |||||||||||||||||||||||||||||||||||||||||||||||
| Hospital | center | Skilled nursing | Hospital | health and | related | |||||||||||||||||||||||||||||||||||||||||||||
| division (a) | division | services | services | Total | hospice | Corporate | costs | Eliminations | Consolidated | |||||||||||||||||||||||||||||||||||||||||
| Revenues | $ | 2,549,992 | $ | 2,254,099 | $ | 775,158 | $ | 200,824 | $ | 975,982 | $ | 60,736 | $ | - | $ | - | $ | (319,046 | ) | $ | 5,521,763 | |||||||||||||||||||||||||||||
| Salaries, wages and benefits | 1,164,486 | 1,085,476 | 679,177 | 144,147 | 823,324 | 45,378 | 120,478 | 16,769 | (96 | ) | 3,255,815 | |||||||||||||||||||||||||||||||||||||||
| Supplies | 283,628 | 112,095 | 2,826 | 189 | 3,015 | 2,438 | 838 | - | - | 402,014 | ||||||||||||||||||||||||||||||||||||||||
| Rent | 189,332 | 198,556 | 6,275 | 228 | 6,503 | 1,366 | 1,681 | 1,819 | - | 399,257 | ||||||||||||||||||||||||||||||||||||||||
| Other operating expenses | 614,436 | 718,263 | 27,239 | 12,757 | 39,996 | 9,817 | 66,981 | 33,937 | (318,950 | ) | 1,164,480 | |||||||||||||||||||||||||||||||||||||||
| Other income | - | - | - | - | - | - | (11,191 | ) | - | - | (11,191 | ) | ||||||||||||||||||||||||||||||||||||||
| Impairment charges | 57,427 | 25,855 | 45,999 | - | 45,999 | - | - | 129,281 | ||||||||||||||||||||||||||||||||||||||||||
| Depreciation and amortization | 74,910 | 50,040 | 7,191 | 5,637 | 12,828 | 1,449 | 26,367 | - | - | 165,594 | ||||||||||||||||||||||||||||||||||||||||
| Interest expense | 500 | 102 | - | - | - | 1 | 66,514 | 13,802 | - | 80,919 | ||||||||||||||||||||||||||||||||||||||||
| Investment income | (7 | ) | (86 | ) | (3 | ) | (1 | ) | (4 | ) | (1 | ) | (933 | ) | - | - | (1,031 | ) | ||||||||||||||||||||||||||||||||
| 2,384,712 | 2,190,301 | 768,704 | 162,957 | 931,661 | 60,448 | 270,735 | 66,327 | (319,046 | ) | 5,585,138 | ||||||||||||||||||||||||||||||||||||||||
|
Income (loss) from continuing operations before income taxes |
$ | 165,280 | $ | 63,798 | $ | 6,454 | $ | 37,867 | $ | 44,321 | $ | 288 | $ | (270,735 | ) | $ | (66,327 | ) | $ | - | (63,375 | ) | ||||||||||||||||||||||||||||
| Income tax benefit | (7,104 | ) | ||||||||||||||||||||||||||||||||||||||||||||||||
| Loss from continuing operations | $ | (56,271 | ) | |||||||||||||||||||||||||||||||||||||||||||||||
|
Capital expenditures, excluding acquisitions (including discontinued operations): |
||||||||||||||||||||||||||||||||||||||||||||||||||
| Routine | $ | 46,393 | $ | 34,304 | $ | 1,700 | $ | 238 | $ | 1,938 | $ | 164 | $ | 50,104 | $ | - | $ | - | $ | 132,903 | ||||||||||||||||||||||||||||||
| Development | 67,321 | 19,167 | - | - | - | 1,167 | - | - | - | 87,655 | ||||||||||||||||||||||||||||||||||||||||
| $ | 113,714 | $ | 53,471 | $ | 1,700 | $ | 238 | $ | 1,938 | $ | 1,331 | $ | 50,104 | $ | - | $ | - | $ | 220,558 | |||||||||||||||||||||||||||||||
| Year ended |
||||||||||||||||||||||||||||||||||||||||||||||||||
| Nursing | Rehabilitation division | Home | Transaction- | |||||||||||||||||||||||||||||||||||||||||||||||
| Hospital | center | Skilled nursing | Hospital | health and | related | |||||||||||||||||||||||||||||||||||||||||||||
| division (b) | division (b) | services | services | Total | hospice | Corporate (b) | costs | Eliminations | Consolidated | |||||||||||||||||||||||||||||||||||||||||
| Revenues | $ | 1,973,321 | $ | 2,187,885 | $ | 403,755 | $ | 83,678 | $ | 487,433 | $ | 17,522 | $ | - | $ | - | $ | (306,464 | ) | $ | 4,359,697 | |||||||||||||||||||||||||||||
| Salaries, wages and benefits | 894,345 | 1,080,344 | 356,171 | 62,173 | 418,344 | 12,880 | 99,480 | 357 | (60 | ) | 2,505,690 | |||||||||||||||||||||||||||||||||||||||
| Supplies | 228,157 | 110,266 | 2,003 | 106 | 2,109 | 1,108 | 557 | - | - | 342,197 | ||||||||||||||||||||||||||||||||||||||||
| Rent | 152,986 | 198,105 | 5,644 | 106 | 5,750 | 386 | 145 | - | - | 357,372 | ||||||||||||||||||||||||||||||||||||||||
| Other operating expenses | 490,462 | 693,857 | 11,878 | 2,430 | 14,308 | 3,600 | 48,499 | 4,287 | (306,404 | ) | 948,609 | |||||||||||||||||||||||||||||||||||||||
| Other income | - | - | - | - | - | - | (11,422 | ) | - | - | (11,422 | ) | ||||||||||||||||||||||||||||||||||||||
| Depreciation and amortization | 51,639 | 45,471 | 2,169 | 306 | 2,475 | 234 | 21,733 | - | - | 121,552 | ||||||||||||||||||||||||||||||||||||||||
| Interest expense | 5 | 131 | - | - | - | - | 6,954 | - | - | 7,090 | ||||||||||||||||||||||||||||||||||||||||
| Investment income | (3 | ) | (70 | ) | (5 | ) | (1 | ) | (6 | ) | - | (1,166 | ) | - | - | (1,245 | ) | |||||||||||||||||||||||||||||||||
| 1,817,591 | 2,128,104 | 377,860 | 65,120 | 442,980 | 18,208 | 164,780 | 4,644 | (306,464 | ) | 4,269,843 | ||||||||||||||||||||||||||||||||||||||||
|
Income from continuing operations before income taxes |
$ | 155,730 | $ | 59,781 | $ | 25,895 | $ | 18,558 | $ | 44,453 | $ | (686 | ) | $ | (164,780 | ) | $ | (4,644 | ) | $ | - | 89,854 | ||||||||||||||||||||||||||||
| Provision for income taxes | 33,708 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Income from continuing operations | $ | 56,146 | ||||||||||||||||||||||||||||||||||||||||||||||||
|
Capital expenditures, excluding acquisitions (including discontinued operations): |
||||||||||||||||||||||||||||||||||||||||||||||||||
| Routine | $ | 36,967 | $ | 37,024 | $ | 2,356 | $ | 293 | $ | 2,649 | $ | 66 | $ | 32,190 | $ | - | $ | - | $ | 108,896 | ||||||||||||||||||||||||||||||
| Development | 41,140 | 26,701 | - | - | - | - | - | - | - | 67,841 | ||||||||||||||||||||||||||||||||||||||||
| $ | 78,107 | $ | 63,725 | $ | 2,356 | $ | 293 | $ | 2,649 | $ | 66 | $ | 32,190 | $ | - | $ | - | $ | 176,737 | |||||||||||||||||||||||||||||||
|
(a) Includes loss on divestiture of a hospital of |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
(b) Includes |
||||||||||||||||||||||||||||||||||||||||||||||||||
| Condensed Business Segment Data | ||||||||||||||||||||||||||||||
| (Unaudited) | ||||||||||||||||||||||||||||||
| 2010 Quarters | 2011 Quarters | |||||||||||||||||||||||||||||
| First | Second | Third | Fourth | Year | First | Second | Third | Fourth | Year | |||||||||||||||||||||
| Hospital division data: | ||||||||||||||||||||||||||||||
| End of period data: | ||||||||||||||||||||||||||||||
| Number of hospitals: | ||||||||||||||||||||||||||||||
| Long-term acute care | 83 | 83 | 83 | 89 | 89 | 120 | 120 | 121 | ||||||||||||||||||||||
| Inpatient rehabilitation | - | - | - | - | - | 5 | 5 | 5 | ||||||||||||||||||||||
| 83 | 83 | 83 | 89 | 89 | 125 | 125 | 126 | |||||||||||||||||||||||
| Number of licensed beds: | ||||||||||||||||||||||||||||||
| Long-term acute care | 6,580 | 6,576 | 6,563 | 6,887 | 6,889 | 8,609 | 8,597 | 8,597 | ||||||||||||||||||||||
| Inpatient rehabilitation | - | - | - | - | - | 183 | 183 | 183 | ||||||||||||||||||||||
| 6,580 | 6,576 | 6,563 | 6,887 | 6,889 | 8,792 | 8,780 | 8,780 | |||||||||||||||||||||||
| Revenue mix %: | ||||||||||||||||||||||||||||||
| 56 | 56 | 55 | 58 | 56 | 60 | 60 | 60 | 62 | 60 | |||||||||||||||||||||
| 9 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 7 | 8 | |||||||||||||||||||||
| 10 | 10 | 10 | 9 | 10 | 10 | 10 | 10 | 10 | 10 | |||||||||||||||||||||
| Commercial insurance and other | 25 | 25 | 26 | 24 | 25 | 22 | 22 | 22 | 21 | 22 | ||||||||||||||||||||
| Admissions: | ||||||||||||||||||||||||||||||
| 7,432 | 7,125 | 6,769 | 7,640 | 28,966 | 8,504 | 8,913 | 11,002 | 11,682 | 40,101 | |||||||||||||||||||||
| 997 | 990 | 1,022 | 1,034 | 4,043 | 1,085 | 1,163 | 1,236 | 1,163 | 4,647 | |||||||||||||||||||||
| 1,129 | 1,106 | 936 | 1,071 | 4,242 | 1,172 | 1,348 | 1,609 | </td> | 1,549 | 5,678 | ||||||||||||||||||||
| Commercial insurance and other | 2,262 | 2,048 | 1,978 | 2,020 | 8,308 | 2,282 | 2,290 | 2,669 | 2,853 | 10,094 | ||||||||||||||||||||
| 11,820 | 11,269 | 10,705 | 11,765 | 45,559 | 13,043 | 13,714 | 16,516 | 17,247 | 60,520 | |||||||||||||||||||||
| Admissions mix %: | ||||||||||||||||||||||||||||||
| 63 | 63 | 63 | 65 | 64 | 65 | 65 | 67 | 68 | 66 | |||||||||||||||||||||
| 8 | 9 | 10 | 9 | 9 | 8 | 8 | 7 | 7 | 8 | |||||||||||||||||||||
| 10 | 10 | 9 | 9 | 9 | 9 | 10 | 10 | 9 | 9 | |||||||||||||||||||||
| Commercial insurance and other | 19 | 18 | 18 | 17 | 18 | 18 | 17 | 16 | 16 | 17 | ||||||||||||||||||||
| Patient days: | ||||||||||||||||||||||||||||||
| 202,882 | 195,964 | 179,324 | 198,129 | 776,299 | 219,213 | 237,257 | 275,561 | 285,358 | 1,017,389 | |||||||||||||||||||||
| 47,813 | 45,952 | 48,514 | 46,596 | 188,875 | 45,650 | 45,746 | 48,911 | 48,648 | 188,955 | |||||||||||||||||||||
| 34,524 | 36,000 | 31,186 | 32,868 | 134,578 | 35,639 | 39,503 | 47,819 | 47,738 | 170,699 | |||||||||||||||||||||
| Commercial insurance and other | 75,483 | 70,651 | 70,198 | 69,585 | 285,917 | 70,522 | 72,759 | 83,375 | 84,677 | 311,333 | ||||||||||||||||||||
| 360,702 | 348,567 | 329,222 | 347,178 | 1,385,669 | 371,024 | 395,265 | 455,666 | 466,421 | 1,688,376 | |||||||||||||||||||||
| Average length of stay: | ||||||||||||||||||||||||||||||
| 27.3 | 27.5 | 26.5 | 25.9 | 26.8 | 25.8 | 26.6 | 25.0 | 24.4 | 25.4 | |||||||||||||||||||||
| 48.0 | 46.4 | 47.5 | 45.1 | 46.7 | 42.1 | 39.3 | 39.6 | 41.8 | 40.7 | |||||||||||||||||||||
| 30.6 | 32.5 | 33.3 | 30.7 | 31.7 | 30.4 | 29.3 | 29.7 | 30.8 | 30.1 | |||||||||||||||||||||
| Commercial insurance and other | 33.4 | 34.5 | 35.5 | 34.4 | 34.4 | 30.9 | 31.8 | 31.2 | 29.7 | 30.8 | ||||||||||||||||||||
| Weighted average | 30.5 | 30.9 | 30.8 | 29.5 | 30.4 | 28.4 | 28.8 | 27.6 | 27.0 | 27.9 | ||||||||||||||||||||
| Condensed Business Segment Data (Continued) | ||||||||||||||||||||||||||||||||||||||||
| (Unaudited) | ||||||||||||||||||||||||||||||||||||||||
| 2010 Quarters | 2011 Quarters | |||||||||||||||||||||||||||||||||||||||
| First | Second | Third | Fourth | Year | First | Second | Third | Fourth | Year | |||||||||||||||||||||||||||||||
| Hospital division data (continued): | ||||||||||||||||||||||||||||||||||||||||
| Revenues per admission: | ||||||||||||||||||||||||||||||||||||||||
| $ | 38,078 | $ | 38,938 | $ | 37,675 | $ | 38,368 | $ | 38,272 | $ | 39,439 </td> | $ | 40,089 | $ | 37,408 | $ | 37,643 | $ | 38,503 | |||||||||||||||||||||
| 45,738 | 42,774 | 42,910 | 41,704 | 43,266 | 42,432 | 41,576 | 40,720 | 44,618 | 42,309 | |||||||||||||||||||||||||||||||
| 45,187 | 46,169 | 48,122 | 44,744 | 45,979 | 46,217 | 42,708 | 43,616 | 46,154 | 44,630 | |||||||||||||||||||||||||||||||
| Commercial insurance and other | 56,344 | 59,842 | 61,314 | 61,131 | 59,553 | 54,065 | 56,850 | 57,216 | 52,465 | 55,078 | ||||||||||||||||||||||||||||||
| Weighted average | 42,899 | 43,784 | 43,456 | 43,150 | 43,313 | 42,856 | 43,271 | 41,462 | 41,330 | 42,135 | ||||||||||||||||||||||||||||||
| Revenues per patient day: | ||||||||||||||||||||||||||||||||||||||||
| $ | 1,395 | $ | 1,416 | $ | 1,422 | $ | 1,479 | $ | 1,428 | $ | 1,530 | $ | 1,506 | $ | 1,494 | $ | 1,541 | $ | 1,518 | |||||||||||||||||||||
| 954 | 922 | 904 | 925 | 926 | 1,009 | 1,057 | 1,029 | 1,067 | 1,041 | |||||||||||||||||||||||||||||||
| 1,478 | 1,418 | 1,444 | 1,458 | 1,449 | 1,520 | 1,457 | 1,468 | 1,498 | 1,485 | |||||||||||||||||||||||||||||||
| Commercial insurance and other | 1,688 | 1,735 | 1,728 | 1,775 | 1,730 | 1,749 | 1,789 | 1,832 | 1,768 | 1,786 | ||||||||||||||||||||||||||||||
| Weighted average | 1,406 | 1,416 | 1,413 | 1,462 | 1,424 | 1,507 | 1,501 | 1,503 | 1,528 | 1,510 | ||||||||||||||||||||||||||||||
| 1.21 | 1.21 | 1.19 | 1.17 | 1.19 | 1.21 | 1.22 | 1.17 | 1.14 | 1.18 | |||||||||||||||||||||||||||||||
| Average daily census | 4,008 | 3,830 | 3,579 | 3,774 | 3,796 | 4,122 | 4,344 | 4,953 | 5,070 | 4,626 | ||||||||||||||||||||||||||||||
| Occupancy % | 68.2 | 66.1 | 62.0 | 64.0 | 65.1 | 68.7 | 65.5 | 62.6 | 63.5 | 64.8 | ||||||||||||||||||||||||||||||
| Annualized employee turnover % | 21.8 | 22.6 | 22.3 | 22.0 | 21.2 | 22.1 | 21.4 | 20.3 | ||||||||||||||||||||||||||||||||
| Nursing center division data: | ||||||||||||||||||||||||||||||||||||||||
| End of period data: | ||||||||||||||||||||||||||||||||||||||||
| Number of facilities: | ||||||||||||||||||||||||||||||||||||||||
| Nursing and rehabilitation centers: | ||||||||||||||||||||||||||||||||||||||||
| Owned or leased | 218 | 219 | 222 | 222 | 220 | 220 | 220 | 220 | ||||||||||||||||||||||||||||||||
| Managed | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | ||||||||||||||||||||||||||||||||
| Assisted living facilities | 6 | 7 | 7 | 7 | 6 | 6 | 6 | 6 | ||||||||||||||||||||||||||||||||
| 228 | 230 | 233 | 233 | 230 | 230 | 230 | 230 | |||||||||||||||||||||||||||||||||
| Number of licensed beds: | ||||||||||||||||||||||||||||||||||||||||
| Nursing and rehabilitation centers: | ||||||||||||||||||||||||||||||||||||||||
| Owned or leased | 26,711 | 26,760 | 27,030 | 26,957 | 26,767 | 26,687 | 26,687 | 26,663 | ||||||||||||||||||||||||||||||||
| Managed | 485 | 485 | 485 | 485 | 485 | 485 | 485 | 485 | ||||||||||||||||||||||||||||||||
| Assisted living facilities | 327 | 463 | 463 | 463 | 413 | 413 | 413 | 413 | ||||||||||||||||||||||||||||||||
| 27,523 | 27,708 | 27,978 | 27,905 | 27,665 | 27,585 | 27,585 | 27,561 | |||||||||||||||||||||||||||||||||
| Revenue mix %: | ||||||||||||||||||||||||||||||||||||||||
| 35 | 34 | 33 | 36 | 35 | 38 | 37 | 36 | 33 | 36 | |||||||||||||||||||||||||||||||
| 41 | 41 | 41 | 39 | 40 | 37 | 38 | 38 | 40 | 38 | |||||||||||||||||||||||||||||||
| 6 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | |||||||||||||||||||||||||||||||
| Private and other | 18 | 18 | 19 | 18 | 18 | 18 | 18 | 19 | 20 | 19 | ||||||||||||||||||||||||||||||
| Condensed Business Segment Data (Continued) | ||||||||||||||||||||||||||||||||||||||||
| (Unaudited) | ||||||||||||||||||||||||||||||||||||||||
| 2010 Quarters | 2011 Quarters | |||||||||||||||||||||||||||||||||||||||
| First | Second | Third | Fourth | Year | First | Second | Third | Fourth | Year | |||||||||||||||||||||||||||||||
| Nursing center division data (continued): | ||||||||||||||||||||||||||||||||||||||||
| Patient days (excludes managed facilities): | ||||||||||||||||||||||||||||||||||||||||
| 369,102 | 363,149 | 346,837 | 344,018 | 1,423,106 | 370,395 | 358,760 | 345,362 | 334,156 | 1,408,673 | |||||||||||||||||||||||||||||||
| 1,312,517 | 1,292,246 | 1,289,643 | 1,287,739 | 5,182,145 | 1,232,620 | 1,229,517 | 1,255,418 | 1,248,442 | 4,965,997 | |||||||||||||||||||||||||||||||
| 87,692 | 92,051 | 91,643 | 94,336 | 365,722 | 97,460 | 94,483 | 95,751 | 95,730 | 383,424 | |||||||||||||||||||||||||||||||
| Private and other | 397,550 | 415,921 | 437,413 | 453,357 | 1,704,241 | 425,414 | 435,667 | 436,074 | 441,362 | 1,738,517 | ||||||||||||||||||||||||||||||
| 2,166,861 | 2,163,367 | 2,165,536 | 2,179,450 | 8,675,214 | 2,125,889 | 2,118,427 | 2,132,605 | 2,119,690 | 8,496,611 | |||||||||||||||||||||||||||||||
| Patient day mix %: | ||||||||||||||||||||||||||||||||||||||||
| 17 | 17 | 16 | 16 | 16 | 17 | 17 | 16 | 16 | 17 | |||||||||||||||||||||||||||||||
| 61 | 60 | 60 | 59 | 60 | 58 | 58 | 59 | 59 | 58 | |||||||||||||||||||||||||||||||
| 4 | 4 | 4 | 4 | 4 | 5 | 4 | 5 | 4 | 5 | |||||||||||||||||||||||||||||||
| Private and other | 18 | 19 | 20 | 21 | 20 | 20 | 21 | 20 | 21 | 20 | ||||||||||||||||||||||||||||||
| Revenues per patient day: | ||||||||||||||||||||||||||||||||||||||||
| Medicare Part A | $ | 470 | $ | 469 | $ | 468 | $ | 534 | $ | 485 | $ | 537 | $ | 544 | $ | 550 | $ | 491 | $ | 531 | ||||||||||||||||||||
| Total |
513 | 515 | 519 | 587 | 533 | 579 | 589 | 599 | 544 | 578 | ||||||||||||||||||||||||||||||
| 168 | 171 | 171 | 171 | 170 | 172 | 173 | 174 | 176 | 174 | |||||||||||||||||||||||||||||||
| 398 | 400 | 405 | 432 | 409 | 416 | 420 | 421 | 405 | 415 | |||||||||||||||||||||||||||||||
| Private and other | 238 | 234 | 232 | 228 | 233 | 235 | 240 | 243 | 241 | 240 | ||||||||||||||||||||||||||||||
| Weighted average | 249 | 250 </td> | 249 | 260 | 252 | 267 | 268 | 268 | 258 | 265 | ||||||||||||||||||||||||||||||
| Average daily census | 24,076 | 23,773 | 23,538 | 23,690 | 23,768 | 23,621 | 23,279 | 23,180 | 23,040 | 23,278 | ||||||||||||||||||||||||||||||
| Admissions (excludes managed facilities) | 19,026 | 18,924 | 19,383 | 19,118 | 76,451 | 20,619 | 20,143 | 20,118 | 19,914 | 80,794 | ||||||||||||||||||||||||||||||
| Occupancy % | 89.0 | 87.3 | 86.8 | 86.4 | 87.4 | 86.9 | 85.9 | 85.5 | 85.1 | 85.9 | ||||||||||||||||||||||||||||||
| 33.7 | 35.2 | 34.3 | 33.0 | 34.0 | 32.9 | 33.4 | 33.0 | 32.1 | 32.8 | |||||||||||||||||||||||||||||||
| Annualized employee turnover % | 36.7 | 38.8 | 39.8 | 39.6 | 37.8 | 39.8 | 40.2 | 39.2 | ||||||||||||||||||||||||||||||||
| Rehabilitation division data: | ||||||||||||||||||||||||||||||||||||||||
| Skilled nursing rehabilitation services: | ||||||||||||||||||||||||||||||||||||||||
| Revenue mix %: | ||||||||||||||||||||||||||||||||||||||||
| Company-operated |
59 |
57 |
56 |
51 |
56 |
50 |
36 |
23 |
23 | 30 | ||||||||||||||||||||||||||||||
| Non-affiliated |
41 |
43 |
44 |
49 |
44 |
50 |
64 |
77 |
77 | 70 | ||||||||||||||||||||||||||||||
| Sites of service (at end of period) | 554 | 568 | 595 | 635 | 641 | 1,848 | 1,835 | 1,774 | ||||||||||||||||||||||||||||||||
| Revenue per site | $ | 172,498 | $ | 171,254 | $ | 167,832 | $ | 174,896 | $ | 686,480 | $ | 178,812 | $ | 137,316 | $ | 137,643 | $ | 139,077 | $ | 592,848 | ||||||||||||||||||||
| Therapist productivity % | 83.8 | 84.2 | 82.1 | 78.6 | 82.0 | 80.6 | 81.6 | 80.5 | 80.1 | 80.4 | ||||||||||||||||||||||||||||||
| Hospital rehabilitation services: | ||||||||||||||||||||||||||||||||||||||||
| Company-operated | 96 | 96 | 95 | 95 | 95 | 94 | 54 | 29 | 32 | 42 | ||||||||||||||||||||||||||||||
| Non-affiliated | 4 | 4 | 5 | 5 | 5 | 6 | 46 | 71 | 68 | 58 | ||||||||||||||||||||||||||||||
| Sites of service (at end of period): | ||||||||||||||||||||||||||||||||||||||||
| Inpatient rehabilitation units | - | - | - | 1 | 1 | 104 | 102 | 102 | ||||||||||||||||||||||||||||||||
| LTAC hospitals | 85 | 85 | 85 | 91 | 93 | 97 | 99 | 115 | ||||||||||||||||||||||||||||||||
| Sub-acute units | 7 | 7 | 7 | 7 | 8 | 22 | 23 | 25 | ||||||||||||||||||||||||||||||||
| Outpatient units | 10 | 11 | 11 | 12 | 12 | 119 | 114 | 115 | ||||||||||||||||||||||||||||||||
| Other | 2 | 2 | 4 | 4 | 5 | 8 | 7 | 8 | ||||||||||||||||||||||||||||||||
| 104 | 105 | 107 | 115 | 119 | 350 | 345 | 365 | |||||||||||||||||||||||||||||||||
| Revenue per site | $ | 203,337 | $ | 199,174 | $ | 190,986 | $ | 184,193 | $ | 777,690 | $ | 188,989 | $ | 199,661 | $ | 202,352 | $ | 192,410 | $ | 783,412 | ||||||||||||||||||||
| Annualized employee turnover % | 12.6 | 14.2 | 15.4 | 14.4 | 14.5 | 17.1 | 16.5 | 16.5 | ||||||||||||||||||||||||||||||||
| Earnings (Loss) Per Common Share Reconciliation (a) | ||||||||||||||||||||||||||||||||||||||||
| (In thousands, except per share amounts) | ||||||||||||||||||||||||||||||||||||||||
| Three months ended |
Year ended December 31, | |||||||||||||||||||||||||||||||||||||||
| 2011 | 2010 | 2011 | 2010 | |||||||||||||||||||||||||||||||||||||
| Basic | Diluted | Basic | Diluted | Basic | Diluted | Basic | Diluted | |||||||||||||||||||||||||||||||||
| Earnings (loss): | ||||||||||||||||||||||||||||||||||||||||
| Amounts attributable to Kindred stockholders: | ||||||||||||||||||||||||||||||||||||||||
| Income (loss) from continuing operations: | ||||||||||||||||||||||||||||||||||||||||
| As reported in Statement of Operations | $ | (72,856 | ) | $ | (72,856 | ) | $ | 19,755 | $ | 19,755 | $ | (56,033 | ) | $ | (56,033 | ) | $ | 56,146 | $ | 56,146 | ||||||||||||||||||||
|
Allocation to participating unvested restricted stockholders |
- | - | (347 | ) | (344 | ) | - | - | (1,015 | ) | (1,009 | ) | ||||||||||||||||||||||||||||
| Available to common stockholders | $ | (72,856 | ) | $ | (72,856 | ) | $ | 19,408 | $ | 19,411 | $ </td> | (56,033 | ) | $ | (56,033 | ) | $ | 55,131 | $ | 55,137 | ||||||||||||||||||||
| Discontinued operations, net of income taxes: | ||||||||||||||||||||||||||||||||||||||||
| Income from operations: | ||||||||||||||||||||||||||||||||||||||||
| As reported in Statement of Operations | $ | 1,025 | $ | 1,025 | $ | 1,125 | $ | 1,125 | $ | 2,552 | $ | 2,552 | $ | 798 | $ | 798 | ||||||||||||||||||||||||
|
Allocation to participating unvested restricted stockholders |
- | - | (20 | ) | (20 | ) | - | - | (14 | ) | (14 | ) | ||||||||||||||||||||||||||||
| Available to common stockholders | $ | 1,025 | $ | 1,025 | $ | 1,105 | $ | 1,105 | $ | 2,552 | $ | 2,552 | $ | 784 | $ | 784 | ||||||||||||||||||||||||
| Loss on divestiture of operations: | ||||||||||||||||||||||||||||||||||||||||
| As reported in Statement of Operations | $ | - | $ | - | $ | (456 | ) | $ | (456 | ) | $ | - | $ | - | $ | (453 | ) | $ | (453 | ) | ||||||||||||||||||||
|
Allocation to participating unvested restricted stockholders |
- | - | 8 | 8 | - | - | 8 | 8 | ||||||||||||||||||||||||||||||||
| Available to common stockholders | $ | - | $ | - | $ | (448 | ) | $ | (448 | ) | $ | - | $ | - | $ | (445 | ) | $ | (445 | ) | ||||||||||||||||||||
| Net income (loss): | ||||||||||||||||||||||||||||||||||||||||
| As reported in Statement of Operations | $ | (71,831 | ) | $ | (71,831 | ) | $ | 20,424 | $ | 20,424 | $ | (53,481 | ) | $ | (53,481 | ) | $ | 56,491 | $ | 56,491 | ||||||||||||||||||||
|
Allocation to participating unvested restricted stockholders |
- | - | (359 | ) | (356 | ) | - | - | (1,021 | ) | (1,015 | ) | ||||||||||||||||||||||||||||
| Available to common stockholders | $ | (71,831 | ) | $ | (71,831 | ) | $ | 20,065 | $ | 20,068 | $ | (53,481 | ) | $ | (53,481 | ) | $ | 55,470 | $ | 55,476 | ||||||||||||||||||||
| Shares used in the computation: | ||||||||||||||||||||||||||||||||||||||||
|
Weighted average shares outstanding - basic computation |
51,335 | 51,335 | 38,790 | 38,790 | 46,280 | 46,280 | 38,738 | 38,738 | ||||||||||||||||||||||||||||||||
| Dilutive effect of employee stock options | - | 137 | - | 135 | ||||||||||||||||||||||||||||||||||||
|
Dilutive effect of performance-based restricted shares |
- | 162 | - | 81 | ||||||||||||||||||||||||||||||||||||
|
Adjusted weighted average shares outstanding - diluted computation |
51,335 | 39,089 | 46,280 | 38,954 | ||||||||||||||||||||||||||||||||||||
| Earnings (loss) per common share: | ||||||||||||||||||||||||||||||||||||||||
| Income (loss) from continuing operations | $ | (1.42 | ) | $ | (1.42 | ) | $ | 0.50 | $ | 0.50 | $ | (1.21 | ) | $ | (1.21 | ) | $ | 1.42 | $ | 1.42 | ||||||||||||||||||||
| Discontinued operations: | ||||||||||||||||||||||||||||||||||||||||
| Income from operations | 0.02 | 0.02 | 0.03 | 0.03 | 0.05 | 0.05 | 0.02 | 0.02 | ||||||||||||||||||||||||||||||||
| Loss on divestiture of operations | - | - | (0.01 | ) | (0.01 | ) | - | - | (0.01 | ) | (0.01 | ) | ||||||||||||||||||||||||||||
| Net income (loss) | $ | (1.40 | ) | $ | (1.40 | ) | $ | 0.52 | $ | 0.52 | $ | (1.16 | ) | $ | (1.16 | ) | $ | 1.43 | $ | 1.43 | ||||||||||||||||||||
|
(a) Earnings (loss) per common share are based upon the weighted average number of common shares outstanding during the respective periods. The diluted calculation of earnings (loss) per common share includes the dilutive effect of stock options. The Company follows the provisions of the authoritative guidance for determining whether instruments granted in share-based payment transactions are participating securities, which requires that certain unvested restricted stock be included as a participating security in the basic and diluted earnings (loss) per common share calculation pursuant to the two-class method. |
||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||
| Reconciliation of Non-GAAP Measurements to GAAP Results | ||||||||||||||||||||
| (Unaudited) | ||||||||||||||||||||
| (In thousands, except per share amounts and statistics) | ||||||||||||||||||||
|
In addition to the results provided in accordance with GAAP, the Company has provided a non-GAAP measurement which presents operating results for the fourth quarters and years ended |
||||||||||||||||||||
|
The income tax benefit associated with the excluded charges was calculated using an effective income tax rate of 21.9% and 28.4% for the fourth quarter and year ended |
||||||||||||||||||||
|
This non-GAAP measurement is not intended to replace the presentation of the Company's financial results in accordance with GAAP. The Company believes that the presentation of core operating results provides additional information to investors to facilitate the comparison between periods by excluding certain charges for the fourth quarter and year ended |
||||||||||||||||||||
| Three months ended | Year ended | |||||||||||||||||||
| December 31, | ||||||||||||||||||||
| 2011 | 2010 | 2011 | 2010 | |||||||||||||||||
| Detail of charges excluded from core operating results: | ||||||||||||||||||||
| Transaction costs | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
| Financing costs (in connection with the |
- | - | (13,802 | ) | - | |||||||||||||||
| Severance and retirement costs (in connection with the |
(647 | ) | - | (16,769 | ) | (2,906 | ) | |||||||||||||
| Lease cancellation charge (in connection with the |
(1,819 | ) | - | (1,819 | ) | - | ||||||||||||||
| Loss on hospital divestiture | (1,490 | ) | - | (1,490 | ) | - | ||||||||||||||
| Impairment charges | (102,569 | ) | - | (129,281 | ) | - | ||||||||||||||
| (111,017 | ) | (2,148 | ) | (197,098 | ) | (7,550 | ) | |||||||||||||
| Income tax benefit | 24,313 | 543 | 56,021 | 2,623 | ||||||||||||||||
| Charges net of income taxes | (86,704 | ) | (1,605 | ) | (141,077 | ) | (4,927 | ) | ||||||||||||
| Allocation to participating unvested restricted stockholders | - | 28 | - | 89 | ||||||||||||||||
| Available to common stockholders | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
| Weighted average diluted shares outstanding | 51,335 | 39,089 | 46,280 | 38,954 | ||||||||||||||||
| Diluted loss per common share related to charges | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
| Reconciliation of adjusted operating income before charges: | ||||||||||||||||||||
| Operating income before charges | $ | 200,177 | $ | 159,763 | $ | 762,841 | $ | 582,173 | ||||||||||||
| Detail of charges excluded from core operating results: | ||||||||||||||||||||
| Transaction costs | (4,492 | ) | (2,148 | ) | (33,937 | ) | (4,644 | ) | ||||||||||||
| Severance and retirement costs | (647 | ) | - | (16,769 | ) | (2,906 | ) | |||||||||||||
| Loss on hospital divestiture | (1,490 | ) | - | (1,490 | ) | - | ||||||||||||||
| Impairment charges | (102,569 | ) | - | (129,281 | ) | - | ||||||||||||||
| (109,198 | ) | (2,148 | ) | (181,477 | ) | (7,550 | ) | |||||||||||||
| Reported operating income | $ | 90,979 | $ | 157,615 | $ | 581,364 | $ | 574,623 | ||||||||||||
| Reconciliation of adjusted income from continuing operations before charges: | ||||||||||||||||||||
| Amounts attributable to Kindred stockholders: | ||||||||||||||||||||
| Income from continuing operations before charges | $ | 13,848 | $ | 21,360 | $ | 85,044 | $ </td> | 61,073 | ||||||||||||
| Charges net of income taxes | (86,704 | ) | (1,605 | ) | (141,077 | ) | (4,927 | ) | ||||||||||||
| Reported income (loss) from continuing operations | ( |
) | $ | 19,755 | ( |
) | $ | 56,146 | ||||||||||||
|
Reconciliation of diluted income per common share from continuing operations before charges: |
||||||||||||||||||||
| Diluted income per common share before charges (a) | $ | 0.27 | $ | 0.54 | $ | 1.80 | $ | 1.54 | ||||||||||||
| Charges net of income taxes as computed above | (1.69 | ) | (0.04 | ) | (3.05 | ) | (0.12 | ) | ||||||||||||
| Other | - | - | 0.04 | - | ||||||||||||||||
| Reported diluted income (loss) per common share from continuing operations | ( |
) | $ | 0.50 | ( |
) | $ | 1.42 | ||||||||||||
|
Weighted average diluted shares used to compute diluted income (loss) per common share from continuing operations before charges |
51,371 | 39,089 | 46,587 | 38,954 | ||||||||||||||||
| Reconciliation of effective income tax rate before charges: | ||||||||||||||||||||
| Effective income tax rate before charges | 34.8 | % | 39.1 | % | 36.6 | % | 37.3 | % | ||||||||||||
| Impact of charges on effective income tax rate | -15.9 | % | 0.9 | % | -25.4 | % | 0.2 | % | ||||||||||||
| Reported effective income tax rate | 18.9 | % | 40.0 | % | 11.2 | % | 37.5 | % | ||||||||||||
|
(a) For purposes of computing diluted earnings per common share before charges, income from continuing operations before charges was reduced by |
||||||||||||||||||||
|
|
||||||||||||||||||||
| Reconciliation of Non-GAAP Measurements to GAAP Results (Continued) | ||||||||||||||||||||
| (Unaudited) | ||||||||||||||||||||
| (In thousands) | ||||||||||||||||||||
|
In addition to the results provided in accordance with GAAP, the Company has provided a non-GAAP measurement which presents operating cash flows for the fourth quarters and years ended |
||||||||||||||||||||
|
The income tax benefit associated with the excluded payments was calculated using an effective income tax rate of 38.3% and 30.1% for the fourth quarter and year ended |
||||||||||||||||||||
|
This non-GAAP measurement is not intended to replace the presentation of the Company's operating cash flows in accordance with GAAP. The Company believes that the presentation of adjusted operating cash flows provides additional information to investors to facilitate the comparison between periods by excluding certain payments for the fourth quarters and years ended |
||||||||||||||||||||
| Three months ended | Year ended | |||||||||||||||||||
| December 31, | ||||||||||||||||||||
| 2011 | 2010 | 2011 | 2010 | |||||||||||||||||
|
Reconciliation of net cash flows provided by operating activities to adjusted operating cash flows: |
||||||||||||||||||||
| Net cash provided by operating activities | $ | 35,900 | $ | 59,133 | $ | 153,706 | $ | 209,988 | ||||||||||||
| Adjustments to remove certain payments: | ||||||||||||||||||||
| Financing costs: | ||||||||||||||||||||
| Capitalized as deferred financing costs | - | - | 46,232 | - | ||||||||||||||||
| Charged to interest expense | - | - | 13,074 | - | ||||||||||||||||
| Transaction costs | 4,369 | 2,111 | 33,827 | 3,821 | ||||||||||||||||
| Severance and retirement costs | 1,038 | - | 11,303 | 2,689 | ||||||||||||||||
|
Benefit of reduced income tax payments resulting from financing, transaction, severance and retirement costs |
(2,656 | ) | (543 | ) | (20,502 | ) | (2,623 | ) | ||||||||||||
| 2,751 | 1,568 | 83,934 | 3,887 | |||||||||||||||||
| Adjusted operating cash flows | $ | 38,651 | $ | 60,701 | $ | 237,640 | $ | 213,875 | ||||||||||||
| Reconciliation of Earnings Guidance for 2012 - Continuing Operations | ||||||||||||||||||||
| (Unaudited) | ||||||||||||||||||||
| (In millions, except per share amounts) | ||||||||||||||||||||
|
As of |
As of |
|||||||||||||||||||
| Low | High | Low | High | |||||||||||||||||
| Operating income | $ | 868 | $ | 884 | $ | 911 | $ | 928 | ||||||||||||
| Rent | 434 | 434 | 445 | 445 | ||||||||||||||||
| Depreciation and amortization | 197 | 197 | 200 | 200 | ||||||||||||||||
| Interest, net | 107 | 107 | 110 | 110 | ||||||||||||||||
| Income from continuing operations before income taxes | 130 | 146 | 156 | 173 | ||||||||||||||||
| Provision for income taxes | 54 | 60 | 63 | 69 | ||||||||||||||||
| Income from continuing operations | 76 | 86 | 93 | 104 | ||||||||||||||||
|
Earnings attributable to noncontrolling interests |
(3 | ) | (3 | ) | (4 | ) | (4 | ) | ||||||||||||
|
Income from continuing operations attributable to the Company |
73 | 83 | 89 | 100 | ||||||||||||||||
| Allocation to participating unvested restricted stockholders | (2 | ) | (2 | ) | (2 | ) | (2 | ) | ||||||||||||
| Available to common stockholders | $ | 71 | $ | 81 | $ | 87 | $ | 98 | ||||||||||||
| Earnings per diluted share | $ | 1.35 | $ | 1.55 | $ | 1.65 | $ | 1.85 | ||||||||||||
| Shares used in computing earnings per diluted share | 52.5 | 52.5 | 53.0 | 53.0 | ||||||||||||||||
|
(a) The Company's earnings guidance excludes the effect of (i) any transaction-related charges, (ii) any other reimbursement changes, (iii) any acquisitions or divestitures, (iv) any impairment charges, or (v) any repurchases of common stock. |
||||||||||||||||||||
Executive Vice President and Chief Financial Officer
Source:
| Copyright: | Copyright Business Wire 2012 |
| Wordcount: | 12916 |



AMERICAN NATIONAL INSURANCE CO /TX/ FILES (8-K) Disclosing Change in Directors or Principal Officers
IPC THE HOSPITALIST COMPANY, INC. – 10-K – MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Advisor News
- Trump proposes retirement savings plan for Americans without one
- Millennials seek trusted financial advice as they build and inherit wealth
- NAIFA: Financial professionals are essential to the success of Trump Accounts
- Changes, personalization impacting retirement plans for 2026
- Study asks: How do different generations approach retirement?
More Advisor NewsAnnuity News
- Regulators ponder how to tamp down annuity illustrations as high as 27%
- Annual annuity reviews: leverage them to keep clients engaged
- Symetra Enhances Fixed Indexed Annuities, Introduces New Franklin Large Cap Value 15% ER Index
- Ancient Financial Launches as a Strategic Asset Management and Reinsurance Holding Company, Announces Agreement to Acquire F&G Life Re Ltd.
- FIAs are growing as the primary retirement planning tool
More Annuity NewsHealth/Employee Benefits News
- Kontoor updates executive severance package
- AZ ACA enrollment drops 65,000 as tax credits expire
- Two health care bills advance to Evers' desk
Assembly passes breast cancer screening, postpartum Medicaid bills
- Obamacare sign-ups drop
- NJ DEPARTMENT OF BANKING AND INSURANCE PROVIDES GET COVERED NEW JERSEY OPEN ENROLLMENT UPDATE
More Health/Employee Benefits NewsLife Insurance News